7 articles
How checkpoint inhibitors unleash the immune system to fight cancer.
HER2-targeted therapies that have transformed outcomes in HER2-positive breast cancer.
How ALK rearrangements are detected and treated with ALK inhibitors.
Understanding EGFR alterations and approved targeted therapies for lung cancer.
An overview of biomarkers such as EGFR, ALK, HER2, KRAS, and BRAF.
How molecular profiling and genomic testing inform treatment selection.
An educational overview of cancer treatments that act on specific molecular targets.
